n-methyl-n-propargyl-(1-indanyl)-ammonium hydrochloride has been researched along with tyramine in 1 studies
Studies (n-methyl-n-propargyl-(1-indanyl)-ammonium hydrochloride) | Trials (n-methyl-n-propargyl-(1-indanyl)-ammonium hydrochloride) | Recent Studies (post-2010) (n-methyl-n-propargyl-(1-indanyl)-ammonium hydrochloride) | Studies (tyramine) | Trials (tyramine) | Recent Studies (post-2010) (tyramine) |
---|---|---|---|---|---|
6 | 0 | 0 | 5,823 | 164 | 762 |
Protein | Taxonomy | n-methyl-n-propargyl-(1-indanyl)-ammonium hydrochloride (IC50) | tyramine (IC50) |
---|---|---|---|
trace amine-associated receptor 1 | Homo sapiens (human) | 0.8818 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Finberg, JP; Youdim, MB | 1 |
1 other study(ies) available for n-methyl-n-propargyl-(1-indanyl)-ammonium hydrochloride and tyramine
Article | Year |
---|---|
MAO type B inhibitors as adjunct to L-dopa therapy.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Alkynes; Animals; Brain; Drug Therapy, Combination; Humans; Indans; Isoenzymes; Levodopa; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pargyline; Parkinson Disease; Parkinson Disease, Secondary; Pyridines; Receptors, Dopamine; Selegiline; Structure-Activity Relationship; Tyramine | 1987 |